Premium
Safety and diagnostic accuracy of tumor biopsies in children with cancer
Author(s) -
Interiano Rodrigo B.,
Loh Amos H.P.,
Hinkle Nathan,
Wahid Fazal N.,
Malkan Alpin D.,
Bahrami Armita,
Jenkins Jesse J.,
Mao Shenghua,
Wu Jianrong,
Proctor Kimberly,
Santana Victor M.,
Pappo Alberto S.,
Gold Robert E.,
Davidoff Andrew M.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29167
Subject(s) - medicine , common terminology criteria for adverse events , biopsy , cancer , adverse effect , medical diagnosis , grading (engineering) , overdiagnosis , surgery , radiology , civil engineering , engineering
BACKGROUND Tumor biopsies are central to the diagnosis and management of cancer and are critical to efforts in personalized medicine and targeted therapeutics. In the current study, the authors sought to evaluate the safety and accuracy of biopsies in children with cancer. METHODS All biopsies performed in children at the study institution with a suspected or established diagnosis of cancer from 2003 through 2012 were reviewed retrospectively. Patient characteristics and disease‐related and procedure‐related factors were correlated with procedure‐related complications and diagnostic accuracy using logistic regression analysis. RESULTS A total of 1073 biopsies were performed in 808 patients. Of 1025 biopsies with adequate follow‐up, 79 (7.7%) were associated with an adverse event, 35 (3.4%) of which were minor (grade 1‐2) and 32 (3.1%) of which were major (grade 3‐4) (grading was performed according to the National Cancer Institute Common Terminology Criteria for Adverse Events [version 4.0]). The most common major adverse events were blood transfusion (>10 mL/kg; 24 cases) and infection requiring intravenous antibiotics (6 cases). Eleven deaths (1.4%) occurred within 30 days after the procedure, but the procedure may have contributed to the outcome in only 2 cases. A total of 926 biopsies (90.3%) provided definitive histologic diagnoses. Using multivariable analysis, biopsy site, preprocedure hematocrit level, and body mass index were found to be associated with the risk of postprocedural complications ( P <.0001, P <.0001, and P = .0029, respectively). Excisional biopsy and biopsy site were found to be independently associated with obtaining a diagnostic result ( P = .0002 and P = .0008, respectively). CONCLUSIONS Tumor biopsies in children with cancer are associated with a low incidence of complications and a high rate of diagnostic accuracy. The predictive factors identified for adverse outcomes may aid in risk assessment and preprocedural counseling. Cancer 2015;121:1098–1107 . © 2014 American Cancer Society .